Commenting on the news that cystic fibrosis drug Kaftrio (a triple treatment of ivacaftor, tezacaftor and elexacaftor) will be made available in Wales, Shadow Health and Social Care Minister Andrew RT Davies said:
“Earlier this month, my Welsh Conservative colleague – Angela Burns MS – urged the Health Minister to follow England’s lead over this treatment.
I'm therefore very pleased that the Welsh Labour-led Government has followed in the footsteps of NHS England and agreed a four-year deal with Vertex, which will mean more than 400 people with cystic fibrosis in Wales will be able to access vital treatment such as the potentially ground-breaking Kaftrio, as well as Orkambi."